Showing results (91-100 of 98) with videos related to
Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 98 results.
Diabetes, Obesity & Metabolism|February 28, 2025
Carnitine supplementation improves insulin sensitivity and skeletal muscle acetylcarnitine formation in patients with type 2 diabetesYvonne M H Op den Kamp-Bruls, Yvo J M Op den Kamp, Pandichelvam Veeraiah, et al.Nature Communications|March 22, 2021
Metabolic responses to mild cold acclimation in type 2 diabetes patientsCarlijn M E Remie, Michiel P B Moonen, Kay H M Roumans, et al.Nature Metabolism|December 6, 2024
Cold acclimation with shivering improves metabolic health in adults with overweight or obesityAdam J Sellers, Sten M M van Beek, Dzhansel Hashim, et al.Molecular Metabolism|October 24, 2022
Effects of SGLT2 inhibitor dapagliflozin in patients with type 2 diabetes on skeletal muscle cellular metabolismYvo J M Op den Kamp, Anne Gemmink, Marlies de Ligt, et al.Obesity (Silver Spring, Md.)|September 6, 2023
The tissue-specific metabolic effects of the PPARα agonist ciprofibrate in insulin-resistant male individuals: a double-blind, randomized, placebo-controlled crossover studyVera H W de Wit-Verheggen, Froukje Vanweert, Juho Raiko, et al.Nature Communications|January 12, 2023
Effect of β2-agonist treatment on insulin-stimulated peripheral glucose disposal in healthy men in a randomised placebo-controlled trialSten M M van Beek, Yvonne M H Bruls, Froukje Vanweert, et al.Basic Research in Cardiology|July 24, 2024
Empagliflozin prevents heart failure through inhibition of the NHE1-NO pathway, independent of SGLT2Sha Chen, Qian Wang, Diane Bakker, et al.Cell Metabolism|December 19, 2025
Natural daylight during office hours improves glucose control and whole-body substrate metabolismJan-Frieder Harmsen, Ivo Habets, Andrew D Biancolin, et al.Pageof 10